Simplex Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-54,900
| Closed | -$1K | – | 10197 |
|
|
2023
Q4 | $1K | Sell |
54,900
-13,700
| -20% | -$8.24K | ﹤0.01% | 8632 |
|
|
2023
Q3 | $45K | Buy |
68,600
+11,600
| +20% | +$14.2K | ﹤0.01% | 5913 |
|
|
2023
Q2 | $187K | Buy |
57,000
+55,260
| +3,176% | +$167K | ﹤0.01% | 4374 |
|
|
2023
Q1 | $15K | Sell |
1,740
-2,273
| -57% | -$32.2K | ﹤0.01% | 7218 |
|
|
2022
Q4 | $47K | Sell |
4,013
-74
| -2% | -$1.3K | ﹤0.01% | 5976 |
|
|
2022
Q3 | $86K | Buy |
4,087
+1,104
| +37% | +$29.8K | ﹤0.01% | 5734 |
|
|
2022
Q2 | $72K | Sell |
2,983
-1,744
| -37% | -$59.3K | ﹤0.01% | 6004 |
|
|
2022
Q1 | $235K | Buy |
4,727
+2,160
| +84% | +$107K | ﹤0.01% | 4926 |
|
|
2021
Q4 | $180K | Sell |
2,567
-3,943
| -61% | -$332K | ﹤0.01% | 5346 |
|
|
2021
Q3 | $669K | Buy |
6,510
+290
| +5% | +$27.6K | ﹤0.01% | 3672 |
|
|
2021
Q2 | $625K | Buy |
6,220
+6,182
| +16,268% | +$603K | ﹤0.01% | 3812 |
|
|
2021
Q1 | $351K | Hold |
38
| – | – | ﹤0.01% | 3928 |
|
|
2020
Q4 | $313K | Buy |
38
+10
| +36% | +$853 | ﹤0.01% | 4016 |
|
|
2020
Q3 | $239K | Sell |
28
-10
| -26% | -$1.17K | ﹤0.01% | 3884 |
|
|
2020
Q2 | $355K | Buy |
+38
| New | +$2.09K | ﹤0.01% | 3316 |
|
Simplex Trading's VBIV Position: Q3 2024 in Review
Simplex Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 19,351 shares — an estimated $12K sold.
Simplex Trading first reported a position in VBIV in Q2 2018 and held it in 18 quarters. The position peaked at $212K in Q3 2020. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Simplex Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 19,351 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $12K.
- Simplex Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 18 quarters.
- Simplex Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $212K in Q3 2020.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.